HCC
Hirtle Callaghan & Co’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Buy |
19,457
+896
| +5% | +$61.8K | 0.05% | 57 |
|
|
2025
Q1 | $1.29M | Buy |
+18,561
| New | +$1.29M | 0.05% | 59 |
|
|
2015
Q1 | – | Sell |
-19,890
| Closed | -$842K | – | 261 |
|
|
2014
Q4 | $842K | Sell |
19,890
-1,400
| -7% | -$59.3K | 0.2% | 78 |
|
|
2014
Q3 | $1.01M | Sell |
21,290
-610
| -3% | -$29.1K | 0.17% | 66 |
|
|
2014
Q2 | $1.01M | Hold |
21,900
| – | – | 0.14% | 94 |
|
|
2014
Q1 | $1.01M | Buy |
21,900
+17,375
| +384% | +$802K | 0.17% | 77 |
|
|
2013
Q4 | $836K | Hold |
4,525
| – | – | 0.11% | 96 |
|
|
2013
Q3 | $766K | Buy |
+4,525
| New | +$766K | 0.12% | 99 |
|